Bio-Rad Laboratories, Inc. Named One of the ‘2011 Best Places to Work’ in the San Francisco Bay Area

HERCULES, CA--(Marketwire - May 12, 2011) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), has been named one of the “2011 Best Places to Work in the Bay Area” by the San Francisco Business Times. Bio-Rad appeared in the top 10 ranking in the category of companies that have over 1,501 employees in the Bay Area. This is the second year in a row that Bio-Rad has received this recognition.

To determine who to include on its list, the San Francisco Business Times went directly to the employees of Bay Area companies asking employees to evaluate their satisfaction with their workplaces. Bio-Rad was selected based on its Bay Area employees taking part in an online satisfaction survey earlier this year. The company was recognized for how well it ranked in areas such as how happy their employees are with the work culture, management practices, benefits, and overall compensation.

“It is a great honor to once again be recognized as one of the Best Places to Work in the Bay Area,” said Norman Schwartz, Bio-Rad President and Chief Executive Officer. “It is gratifying to know our efforts at providing a positive work environment are felt among our employees.”

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The Company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The Company employs over 6,800 people globally and had revenues exceeding $1.9 billion in 2010. For more information, visit www.bio-rad.com.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company’s risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.